VIRTUAL

Priorities for Long Covid services, care and research

Virtual

31 January 2023

event details 

Genomics England research seminar

Virtual

31 January 2023

event details 

NORTH AMERICA

BIO CEO and Investor Conference

New York, New York

6-9 February 2023

event details 

International Conference on PharmScience R&D

Las Vegas, Nevada

21-23 February 2023

event details 

Raymond James Annual Institutional Investors Conference

Orlando, Florida

5-8 March 2023

event details 

SOUTH AMERICA

American Society of Clinical Oncology 

Chicago, Illinois 

3-7 June  2022

event details 

Outsourcing in Clinical Trials: Medical Devices USA 2022 

Irvine, California 

8-9 June 2022

event details 

EUROPE

Digital Pharma Advances Conference

London, UK

31 January 2023

event details 

Annual European Healthtech CEO Forum

Zurich, Switzerland

28 February 2023

event details 

SAE Media Group’s Annual RNA Therapeutics Conference

London, UK

8-9 February 2023

event details 

Africa

ESMO Summit Africa

Cape Town, South Africa

10-12 February 2023 

event details 

MIDDLE EAST

Outsourcing in Clinical Trials & Clinical Trial Supply Israel

Tel Aviv, Israel

6-7 February 2023 

event details 

ASIA PACIFIC

Outsourcing in Clinical Trials & Clinical Trial Supply Israel

Souel, South Korea

6-7 February 2023 

event details 

Go to article: Home | CRISPR gene therapies cut through in 2023Go to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: TripletreeGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: HOF SonderanlagenbauGo to article: Owen Mumford Company InsightGo to article: Owen Mumford AidaptusGo to article: CommentGo to article: High hopes for mRNA anti-cancer vaccines with early successesGo to article: Cell therapies might revolutionise treatment for multiple sclerosis patientsGo to article: Downturn for top biopharma companies as Covid-19 vaccine demand falls in Q3Go to article: Inflation threatens supply of life-saving generics to EuropeGo to article: Data is the key to a safer and more controlled pharmaceutical cold-chainGo to article: Molnar-Institute Company Insight Go to article: Molnar-InstituteGo to article: In DepthGo to article: CRISPR gene therapies: Is 2023 a milestone year in the making?Go to article: Tracking the ups and downs of pharma dealsGo to article: Regulation starts to catch up with AI in pharmaGo to article: Next on trial diversity: Embracing participants with cognitive impairmentGo to article: Digital twins: The next frontier to ease clinical trial conductGo to article: CMO Moves: Regulatory catalysts for therapy manufacturing -JanuaryGo to article: EventsGo to article: Next issue